BDC Update: Saratoga Investment
January 16, 2023
Last week, Saratoga Investment (SAR) reported its calendar IVQ results through the quarter that ended in November - the BDC's fiscal third quarter. SAR always gets more scrutiny from us than some other BDCs because of its outlier status on the calendar, reporting its results weeks before the BDC pack, most of whom won't be disclosing their performance till February. If you're interested in an in-depth review, check out our full-length review of all aspects of the BDC's performance in the BDC Reporter.
We've been bullish on SAR's earnings and dividend outlook since we started coverage in Best Ideas, as you'll see by reading the prior updates below from July, August, and October below. This is largely because the BDC has been a prime example of how we've needed to constantly revise our 5-year projections, Target Price, and valuation throughout 2022. Don't blame us but the unprecedented increase in the base borrowing rate by the Federal Reserve, whose impact has shown up in different ways for every BDC out there.
In the case of SAR, in just 9 months, the average portfolio yield on its income-producing loans has increased by 23% - the biggest such move in the principal driver of earnings in its history. With virtually all the BDC's loan portfolio being floating rate (i.e. increasing income) and most of its debt fixed rate (i.e. not increasing cost), the result has been a spectacular jump in recurring net investment income. Just in this last quarter, adjusted net investment income per share jumped 31%!
To Each Their Own
We've been saying in the BDC Reporter that the entire BDC sector has been challenged by this abundance of sudden riches and had to adapt their dividend payout policies - which vary widely from BDC to BDC. SAR is no exception and has made our prognostication task all the harder by going from being uber-conservative in its dividend policy to uber-generous, as we'll discuss.
All this is to prepare you - dear reader - for yet another (upward) change to the 5-year dividend projection, the Target Price, and the potential Total Return of SAR in the wake of its latest results.
Before we get to that, we'd also like to point out that the BDC surprised us by paying out 5 distributions in calendar 2022, increasing the year's payout from the $2.13 per share we calculated in October to $2.81, thanks to SAR's decision to greatly increase its quarterly dividend to $0.68, and set the record date in 2022. This does not impact our projections or valuation because our numbers begin now in 2023 and roll through to 2027, but still deserves a mention for anyone following closely.
Now to justify ourselves. The dividend projection is not unreasonable given that the current annualized dividend payout rate is already $2.72 and the annualized adjusted net investment income per share is $3.0800. Plus, SAR's management let us all know on their latest conference call that earnings would have been even higher if the latest Fed Funds rate had been applied throughout the November quarter. (Then there's the impact of even more rate increases coming in 2023). The analysts, too, have woken up to the almost certain higher earnings as you'll see in the Expected Return Table, increasing the projected EPS for FY 2024 to $2.92, from $2.61 previously.
In fact, we expect earnings to far exceed distributions in 2023 as the BDC is likely to squirrel away taxable earnings to support its dividend in future years when rates decrease. We're likely to see a mixture of regular and special distributions as management tries to keep the total annual payouts from fluctuating too much. Will we get the perfectly even $2.9000 a year we've projected? Probably not, but the $14.5 per share payout in aggregate is defensible.
Now For Something Completely Different
Understandably, the 15.0x Terminal multiple might seem aggressive. However, our long experience in the field suggests that this could yet occur even if the current multiple of price to projected payout is only 9.3x. Partly that reflects the current risk-off environment in a BDC sector trading (16%) below its April 2022 high. In SAR's case, the high multiple is also due to the prospective net realized gains that might be achieved. Even now 7.0% of the BDC's portfolio is invested in equity, whose value is $25mn higher than what was paid for. There are many companies in the SAR portfolio that might - in happier times - be sold for big gains, and which would supplement recurring earnings.
These Things Happen
The BDC has increased its NAV Per Share by 27% since the end of 2017 - more than any other - on the back of these sorts of gains. We've seen other lower middle market-focused BDCs like Main Street and Fidus Investment trade at unholy multiples of their distributions because of this capacity to generate earnings from both lending and investing. SAR is no different and that's why the seemingly absurd 15.0x multiple.
Although SAR's current stock price is hardly in the doldrums, trading 34% above its 52-week low; (4%) below its 52 high, and only (4%) below its net book value per share, we're a believer in our base scenario of a Target Price of $43.50. If we're wrong, and the multiple does not reach over 12.5x, that's still a first-rate return and good enough for us. We've been looking for a new addition to our Model Portfolio, and SAR fits the bill for a profitable long-term hold. We'll be adding SAR to the Model Portfolio on Tuesday.
October 6, 2022
SAR is always the first to report quarterly earnings given its books close 30 days before everyone else. Calendar IIIQ 2022 results - through August 2022 - were encouraging in a variety of ways, as mostly spelled out in our BDC Reporter article about the highlights of this period's conference call, which happened on October 5, 2022. To quickly summarize, Core Net Investment Income Per Share at $0.58, exceeded the prior quarter by 9%. NAV Per Share - a metric that one should expect to take a beating in these unsettled times - was off only (1.5%) and SAR managed to book a realized gain as well. Most importantly of all, we took a deep dive into the 50 company-plus portfolio and found very few trouble spots that might bring down income in the near term.
The only non-performing loan is to the travel software company Knowland Group. A resolution is being negotiated and - for a second quarter in a row - SAR suggested the debt could be returned to performing status but in Pay-In-Kind form. If so, that would be good for income but still leaves open whether the company will recover.
There are two other companies of concern: Pepper Palace - a specialty food retailer - and Zollege PBC - helping people get employment in the dental sector. Long story short: both companies could yet turn around; income is being paid. If things don't work out - as happens - their failure would be more than offset by the much higher income on its way to SAR from higher rates. Just how "impactful" those rate increases could be is made clear in SAR's latest 10-Q, which says a 200 basis point increase in rates from the level in August could boost Net Investment Income Per Share by $1.16, a 57% jump over the annualized level as of August. Even a 100 basis points, adds $0.66 in EPS - 28% higher.
As management is quick to note - and with good reason - SAR also benefits from being financed almost completely by long-term, fixed-rate debt from the SBA or investors, with very few covenants. That makes SAR well insulated from any future market shocks that might cause other BDCs to default under their revolving loan agreements, and/or lose access to their liquidity. Nobody is invulnerable if things get bad enough - and the SBIC can require SAR's SBA-financed subsidiaries to not dividend up earnings to the parent if heavy losses are occurring in those vehicles. That seems highly unlikely from what we've seen in the past and currently.
That's a 13% increase but only assumes - if all earnings get paid out - a 4% increase over the current EPS running rate. Our friends in the analyst community are projecting EPS in FY 2024, which ends in February 2024, of $2.34. We admit to being more bullish, but the difference is not that material.
Even in an alternative more modest scenario where we assume SAR's distribution does not increase for the next 5 years over its most recent level ($0.54/$2.16) and cut back the terminal multiple we've been using to 12.5x from 15.0x, SAR still offers up a 14.5% annual return over 5 years. Not shabby for standing still. Still, we have confidence that SAR is still going places.
August 29, 2022
Higher. At Long Last.
SAR has announced an increase in its regular distribution for its fiscal second quarter - which corresponds to the calendar third quarter of 2022 - to $0.54 This also might be the last such announcement for this calendar year, here in the dog days of summer.
After three quarters in a row of paying out $0.53, SAR has upped the distribution, as discussed in the BDC Reporter's Daily News Feed. For the year, this brings the total payout to $2.13. That's below our projection for the period of $2.18, as we were innocently expecting at the end of 2021 that SAR would continue in 2022 its trend of upping its distribution by 1 cent a share every quarter. Instead, management left its distribution level unchanged, causing our full-year estimate to be off by( 2%), which will hardly make a difference over a 5-year time frame.
Chances are SAR - which does not tend to pay "specials" - is done announcing distributions that have a 2022 ex-date. As a result, we've extended the projection to 2027. (The Expected Return Table is on a 5-year rolling schedule). Income projections in the table will use the 2023-2027 years, including the just added year as the terminal one to calculate the Terminal Price.
Now we're facing the challenge that investors and analysts will be contending with for many quarters to come: projecting future earnings and dividends in an environment where the reference rate is constantly changing thanks to the Fed; months pass before SAR's borrowers have to pay a higher yield and a host of other factors will vary quarter to quarter. After all, SAR - and other BDCs - might see its investment income increase from higher rates and use the opportunity to reduce total investments. Or, the manager might retain more of the earnings given the availability of a surplus, which will complicate estimating distributions to come. Also, credit losses will occur - both normally and because of the strain of higher rates - which will erode the income benefit.
Because of its 10-Q, we do know, though, how much SAR estimates a 100 basis point or 200 basis point increase in the reference rate would do to boost net investment income (all the benefit would come from higher interest, there would be no higher interest expense due to all debt being fixed rate and SAR seems not to have accounted for higher incentive fees). For 100 basis points, we get a $7mn increase in NII or $0.57 per share, for 200 basis points $14mn, or $1.19 per share. Even the more modest rate increase would result in a huge benefit - and raise the yield from 7.7% to 8.7%.
For our part, we expect a 200 basis point increase over the level at May 2022 - which was 1.0% - is a pretty safe bet, given that the current Fed Funds rate is 2.5%, and almost certainly going to be 3.0% (or higher) when the September revision kicks in. For SAR, the full effect might not be felt till late in the calendar year or in early 2023, but a tsunami of higher income is almost certainly on its way.
Admittedly by 2024, the Fed might bring rates down. We are assuming the reference rate will fall back to 2.0% in the longer run, giving SAR one year of potentially very large income increases and then a still higher-than-before yield (all things being equal).
Translating all the above into annual dividend projections is more art than science. At the moment - and with a depressing lack of guidance from management - we are projecting 2023's distribution will jump to $2.41 - probably in a series of quarterly increases to the quarterly payout. From 2024 on, and through the annual payout is being pegged at $2.60. That's a big jump over the annualized $2.16 latest distribution of $0.54 - a 20% increase.
Still, that's way below how high distributions could go on a pro-forma basis. We'll be the first to admit we've undershot the mark. These projections may need to be revised regularly - hopefully to the upside.
Eyes Wide Open
We know this sounds fantastical (way in excess of SAR's 73% total return over the last 5 years - using Seeking Alpha data), but we'll be seeing more and more of these upgrades to our BDC valuations as the months go by and rates start to rise. A built-in assumption is that the reference rate - once 0%-0.25% - will not be round-tripping in the years ahead, but will ultimately settle back to around 2.0% - well above the level of prior BDC "floors" and even where we were at the end of March 2022. This historic shift in the cost of capital should remake all BDCs' ROEs and ROAs well into the decade.
July 8, 2022
Saratoga Investment (SAR) has in the last couple of days released its quarterly earnings through May 2022; filed a 10-Q; published a detailed Investment Presentation and held its periodic conference call. Over in the BDC Reporter, we wrote an article in advance of earnings and another just after - comparing what we anticipated the results might look like and what actually transpired. Likewise, in the BDC Credit Reporter, we've already written reports on two underperforming companies, including SAR's just announced one and only non-accrual, out of 45 companies and two investment vehicles. In our database, we've plugged in all the latest numbers and updated the Investor Tools in the BDC Reporter: BDC NAV Change Table and the BDC Credit Table.
In other words, we've done our homework - made easier because SAR reports results nearly a month before any other BDC. After all that, we've reviewed the 5-year dividend and price target projections which guides our buying decisions for every public BDC we track, and changed absolutely nothing.
Nothing To Write Home About
Admittedly, the mid-sized BDC - which has just less than $1.0bn in portfolio assets - did not have a particularly good calendar second quarter/fiscal first quarter of 2022. As noted, there was a new non-accrual where there had been none before, resulting in lost interest income, and the possibility of a material net loss one day. Another portfolio company went from performing to underperforming, albeit still paying interest. Then there were unrealized write-downs - due to difficult market conditions - for both SAR's solitary CLO investment and its recently launched off-balance sheet joint venture. Earnings more or less met the analysts' expectations, but only because the advisor did not earn an incentive fee, and actually credited back compensation previously charged. Leverage - both on a regulatory and GAAP basis - closed the quarter at high levels as the BDC bulked up on new portfolio investments. Finally, after quarter after quarter of increasing net book value per share, SAR recognized a (2.2%) drop in this key - if overused - metric.
Nonetheless, we don't see any current threat to the BDC's earnings and projected distributions. That's partly due to the full-quarter impact of a bigger income-generating portfolio going forward and the increase in rates that is beginning. The BDC projects Net Investment Income Per Share (NIIPS) will increase by $0.57 annually on just a 100 basis points increase in the reference rate, and we may get much more than that. No wonder the analyst consensus for FY 2024 is for NIIPS of $2.31, well above our dividend projection.
We do worry about SAR's high leverage levels, but are consoling ourselves with the fact that virtually all the debt is medium to long-term; virtually covenant free and with a fixed yield. Likewise, SAR has a history of quality credit underwriting and should be able to withstand the recessionary conditions ahead, even if asset values drop for a period. The CLO has been through the Great Recession and survived and should do so again.
Not The Best
Unfortunately, and despite a drop in SAR's price following the IIQ 2022 results, the projected return in our model - while high at 16.5% per annum over the next half-decade - is still much lower than what we could achieve elsewhere. The BDC sector price slump that began April 21, 2022, is causing many long-term returns to look very juicy. There are multiple BDCs that promise annual returns for the long-term investor in excess of 20%, or even 30%. As a result, SAR remains a good buy, but there are far better alternatives elsewhere in our coverage universe. That could change if SAR - trading close to its 52-week low - drops further in price.